Biomarker may flag early pregnancy risk - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Biomarker may flag early pregnancy risk

A protein was linked experimentally to trophoblast invasion.

  • By

  • Andrea Surnit

  • September 4, 2026

  • 4 min

Share

  • 1

    Low maternal serum isthmin-2 levels in the first trimester may indicate increased risk of preeclampsia or fetal growth restriction.

  • 2

    The study analyzed samples from 3 prospective pregnancy cohorts, including 4,512 nulliparous patients with singleton pregnancies.

  • 3

    At approximately 12 weeks, low ISM2 was the strongest signal associated with preeclampsia, fetal growth restriction, and composite outcomes.

  • 4

    Lower ISM2 levels at 12 weeks correlated with greater uterine artery resistance at 20 weeks among cases but not controls.

  • 5

    The study suggests ISM2 is necessary for trophoblast invasion and promotes migration in cells lacking endogenous ISM2.

Original Source(s)

Biomarker may flag early pregnancy risk

  • by Andrea Surnit

  • September 4, 2026

Related Content

Top 10 FDA Recalls Physicians Should Know

A structured overview of recent FDA recalls, corrections, and alerts involving medications, ventilators, insulin delivery systems, cardiovascular devices, anesthesia products, and other equipment used in clinical practice.

Less Sitting in Pregnancy Tied to Lower Risk

Pregnant patients who sat less and moved more at light intensity had a lower risk of adverse outcomes in a prospective cohort study, but the findings do not prove causation.

Taxonomy of access to mental healthcare for economically marginalized women during a public health crisis: a qualitative study of obstetric professionals and perinatal women during the COVID-19 pandemic